全文获取类型
收费全文 | 14074篇 |
免费 | 634篇 |
国内免费 | 60篇 |
专业分类
耳鼻咽喉 | 151篇 |
儿科学 | 363篇 |
妇产科学 | 360篇 |
基础医学 | 1925篇 |
口腔科学 | 369篇 |
临床医学 | 931篇 |
内科学 | 2688篇 |
皮肤病学 | 292篇 |
神经病学 | 1334篇 |
特种医学 | 397篇 |
外国民族医学 | 1篇 |
外科学 | 1731篇 |
综合类 | 39篇 |
一般理论 | 2篇 |
预防医学 | 1839篇 |
眼科学 | 587篇 |
药学 | 1058篇 |
中国医学 | 27篇 |
肿瘤学 | 674篇 |
出版年
2021年 | 112篇 |
2020年 | 80篇 |
2019年 | 116篇 |
2018年 | 174篇 |
2017年 | 124篇 |
2016年 | 130篇 |
2015年 | 173篇 |
2014年 | 215篇 |
2013年 | 306篇 |
2012年 | 865篇 |
2011年 | 1027篇 |
2010年 | 362篇 |
2009年 | 266篇 |
2008年 | 961篇 |
2007年 | 1039篇 |
2006年 | 987篇 |
2005年 | 1086篇 |
2004年 | 1048篇 |
2003年 | 930篇 |
2002年 | 876篇 |
2001年 | 697篇 |
2000年 | 782篇 |
1999年 | 419篇 |
1998年 | 100篇 |
1997年 | 75篇 |
1996年 | 74篇 |
1995年 | 66篇 |
1994年 | 40篇 |
1993年 | 41篇 |
1992年 | 100篇 |
1991年 | 93篇 |
1990年 | 111篇 |
1989年 | 99篇 |
1988年 | 89篇 |
1987年 | 71篇 |
1986年 | 76篇 |
1985年 | 81篇 |
1984年 | 54篇 |
1983年 | 66篇 |
1982年 | 33篇 |
1981年 | 32篇 |
1979年 | 69篇 |
1978年 | 36篇 |
1977年 | 37篇 |
1974年 | 45篇 |
1973年 | 36篇 |
1972年 | 33篇 |
1971年 | 37篇 |
1969年 | 40篇 |
1968年 | 32篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Balázs Nemes Réka P. Szabó Dávid Péntek Ildikó Nagy Gergely Ivády Bettina Kárai Eszter Szánthó Zsuzsa Hevessy Sándor Sipka Gergő J. Szőllősi Sándor Baráth 《Transplantation proceedings》2021,53(5):1423-1432
IntroductionThe usage of extended-criteria donors (ECD) became a routinely accepted manner in the last decade. ECD is a potential risk factor for antibody-mediated rejection. Analysis of lymphocyte subsets might be a complementary diagnostic toolkit because there is limited knowledge about this term.MethodBetween May 12, 2016, and September 4, 2019, a total of 130 patients who had undergone kidney transplant were investigated. Patients were divided in ECD and standard criteria donor (SCD) groups. Blood samples were collected before the operation, then in the first week and after 30, 60, 180, and 365 days. Besides routine laboratory tests, multicolor flow cytometry was performed for lymphocyte subsets.ResultsECD grafts were transplanted to older recipients. The number of CD4+ cells increased in the SCDs from the first week to until the end of first month, and then decreased. The number of CD4+ cells decreased from the beginning of the study until the end of first year to 66% of its original value in ECDs. At the first month, the number of CD19+ cells was higher in SCD compared with ECD cases; the number then decreased in both groups. T-regulatory cells had a drop at the first week that lasted until the first month. A bigger increase in SCD and a moderate increase in ECD group were then observed. The kinetics of CD19+ and CD19+ naive cells are similar in the ECD and SCD groups. In the SCD group, cell count decreased in both CD19+ (13%) and CD19+ naive (12%) between third and sixth month. The count of CD19+ cells decreased by 9%, but the count of CD19+ naive cells increased by 11% between the sixth month and first year.DiscussionThe prolonged postoperative uremic state caused by the poorer initial function, together with an aging immune system, explains the weaker immune response in ECD patients, which may be the cause of the decreased number of memory and regulatory T cells. Older patients with an ECD graft need a tailored, personalized, and less aggressive immunosuppressive treatment. 相似文献
2.
V. Papp A. Iljicsov C. Rajda M. Magyari N. Koch‐Henriksen T. Petersen G. Jakab I. Deme F. Nagy P. Imre Z. Lohner K. Kovcs A. J. Birks . Kves G. Rum Z. Nagy L. Kernyi L. Vcsei K. Bencsik Z. Jobbgy P. Diszeghy L. Horvth G. Galntai J. Kasza G. Molnr M. Sim M. Stori C. Rzsa P. cs T. Berki G. Lovas S. Komoly Z. Illes 《European journal of neurology》2020,27(2):308-317
3.
4.
5.
6.
Béla Nagy Zsolt Bene Zsolt Fejes Sonya L. Heltshe David Reid Nicola J. Ronan Yvonne McCarthy Daniel Smith Attila Nagy Elizabeth Joseloff György Balla János Kappelmayer Milan Macek Scott C. Bell Barry J. Plant Margarida D. Amaral István Balogh 《Journal of cystic fibrosis》2019,18(2):271-277
Background
We have recently shown that human epididymis protein 4 (HE4) levels correlate with the severity of cystic fibrosis (CF) lung disease. However, there are no data on how HE4 levels alter in patients receiving CFTR modulating therapy.Methods
In this retrospective clinical study, 3 independent CF patient cohorts (US-American: 29, Australian: 12 and Irish: 19 cases) were enrolled carrying at least one Class III CFTR CF-causing mutation (p.Gly551Asp) and being treated with CFTR potentiator ivacaftor. Plasma HE4 was measured by immunoassay before treatment (baseline) and 1–6?months after commencement of ivacaftor, and were correlated with FEV1 (% predicted), sweat chloride, C-reactive protein (CRP) and body mass index (BMI).Results
After 1?month of therapy, HE4 levels were significantly lower than at baseline and remained decreased up to 6?months. A significant inverse correlation between absolute and delta values of HE4 and FEV1 (r?=??0.5376; P?<?.001 and r?=??0.3285; P?<?.001), was retrospectively observed in pooled groups, including an independent association of HE4 with FEV1 by multiple regression analysis (β?=??0.57, P?=?.019). Substantial area under the receiver operating characteristic curve (ROC-AUC) value was determined for HE4 when 7% mean change of FEV1 (0.722 [95% CI 0.581–0.863]; P?=?.029) were used as classifier, especially in the first 2?months of treatment (0.806 [95% CI 0.665–0.947]; P?<?.001).Conclusions
This study shows that plasma HE4 levels inversely correlate with lung function improvement in CF patients receiving ivacaftor. Overall, this potential biomarker may be of value for routine clinical and laboratory follow-up of CFTR modulating therapy. 相似文献7.
8.
Krisztián Szigeti Ildikó Horváth Dániel S Veres Bernadett Martinecz Nikolett Lénárt Noémi Kovács Erika Bakcsa Alexa Márta Mariann Semjéni Domokos Máthé ádám Dénes 《Journal of cerebral blood flow and metabolism》2015,35(12):1921-1929
Inflammation that develops in the brain and peripheral organs after stroke contributes profoundly to poor outcome of patients. However, mechanisms through which inflammation impacts on brain injury and overall outcome are improperly understood, in part because the earliest inflammatory events after brain injury are not revealed by current imaging tools. Here, we show that single-photon emission computed tomography (NanoSPECT/CT Plus) allows visualization of blood brain barrier (BBB) injury after experimental stroke well before changes can be detected with magnetic resonance imaging (MRI). Early 99mTc-DTPA (diethylene triamine pentaacetic acid) signal changes predict infarct development and systemic inflammation preceding experimental stroke leads to very early perfusion deficits and increased BBB injury within 2 hours after the onset of ischemia. Acute brain injury also leads to peripheral inflammation and immunosuppression, which contribute to poor outcome of stroke patients. The SPECT imaging revealed early (within 2 hours) changes in perfusion, barrier function and inflammation in the lungs and the gut after experimental stroke, with good predictive value for the development of histopathologic changes at later time points. Collectively, visualization of early inflammatory changes after stroke could open new translational research avenues to elucidate the interactions between central and peripheral inflammation and to evaluate in vivo ‘multi-system'' effects of putative anti-inflammatory treatments. 相似文献
9.
Sebestyén Anna Dankó Titanilla Sztankovics Dániel Moldvai Dorottya Raffay Regina Cervi Catherine Krencz Ildikó Zsiros Viktória Jeney András Petővári Gábor 《Cancer metastasis reviews》2021,40(4):989-1033
Cancer and Metastasis Reviews - Despite advancements in cancer management, tumor relapse and metastasis are associated with poor outcomes in many cancers. Over the past decade, oncogene-driven... 相似文献
10.